SOJOURN |
MR6S4 |
SEVOFLURANE |
MR-6S4 |
ULTANE |
SOJOURN® |
SEVOFLURAN |
1,1,1,3,3,3-HEXAFLUORO-2-(FLUOROMETHOXY)PROPANE |
HFE-347MMZ1 |
ULTANE® |
chembl:CHEMBL1200694 |
chemidplus:28523-86-6 |
pubchem.compound:5206 |
rxcui:36453 |
drugbank:01236 |
Drug Class | anesthetics, inhalation |
Year of Approval | 1995 |
FDA Approval | 1995 |
Drug Class | small molecule |
Drug Indications | Anesthetics, Inhalation |
n/a |
other/unknown |
Trial Name | - |
Novel drug target | Established target |
n/a |
Trial Name | - |
Novel drug target | Established target |
agonist (activating) |
Trial Name | - |
Novel drug target | Established target |
Mechanism of Interaction | Glycine receptor (alpha-1/beta) positive modulator |
inducer (activating) |
Trial Name | - |
Novel drug target | Established target |
antagonist (inhibitory) |
Trial Name | - |
Novel drug target | Established target |
n/a |
Mechanism of Interaction | Potassium channel subfamily K member 18 opener |
Direct Interaction | yes |
n/a |
Mechanism of Interaction | Potassium channel subfamily K member 10 opener |
Direct Interaction | yes |
n/a |
Mechanism of Interaction | Potassium channel subfamily K member 9 opener |
Direct Interaction | yes |
n/a |
Mechanism of Interaction | Potassium channel subfamily K member 3 opener |
Direct Interaction | yes |
n/a |
Mechanism of Interaction | Potassium channel subfamily K member 2 opener |
Direct Interaction | yes |
n/a |
Direct Interaction | yes |
Mechanism of Interaction | Glycine receptor (alpha-1/beta) positive modulator |
positive modulator (activating) |
agonist (activating) |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
Direct Interaction | yes |
Trial Name | - |
positive modulator (activating) |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
Direct Interaction | yes |
positive modulator (activating) |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
Direct Interaction | yes |
positive modulator (activating) |
Direct Interaction | yes |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
positive modulator (activating) |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
Direct Interaction | yes |
positive modulator (activating) |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
Direct Interaction | yes |
positive modulator (activating) |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
Direct Interaction | yes |
positive modulator (activating) |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
Direct Interaction | yes |
positive modulator (activating) |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
Direct Interaction | yes |
positive modulator (activating) |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
Direct Interaction | yes |
positive modulator (activating) |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
Direct Interaction | yes |
positive modulator (activating) |
Direct Interaction | yes |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
positive modulator (activating) |
Direct Interaction | yes |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
positive modulator (activating) |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
Direct Interaction | yes |
positive modulator (activating) |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
Direct Interaction | yes |
positive modulator (activating) |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
Direct Interaction | yes |
SEVOFLURANE | Primary Drug Name |
Year of Approval | 1995 |
Drug Class | anesthetics, inhalation |
Drug Indications | Anesthetics, Inhalation |
Drug Class | small molecule |
FDA Approval | 1995 |
D0W6ZF | TTD Drug ID |